Back
Matinas BioPharma Holdings Vs. Madrigal Pharmaceuticals Industry Stock Comparison
Sell
38
MTNB
Matinas BioPharma Holdings
Last Price:
0.62
Seasonality Move:
10.35%
Buy
60
MDGL
Madrigal Pharmaceuticals
Last Price:
311.26
Seasonality Move:
35.27%
Sell
38
Matinas BioPharma Holdings (MTNB)
is a Sell
Is Matinas BioPharma Holdings a Buy, Sell or Hold?
- The current Matinas BioPharma Holdings [MTNB] share price is $0.71. The Score for MTNB is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- MTNB is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Madrigal Pharmaceuticals (MDGL)
is a Buy
Is Madrigal Pharmaceuticals a Buy, Sell or Hold?
- The current Madrigal Pharmaceuticals [MDGL] share price is $315.15. The Score for MDGL is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- MDGL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MTNB Stock Price Chart
What is Matinas BioPharma Holdings's stock price today?
-
The Matinas BioPharma Holdings share price today is $0.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MTNB is experiencing slight buying pressure.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals's stock price today?
-
The Madrigal Pharmaceuticals share price today is $315.15
The current trend is moderately bullish and MDGL is experiencing selling pressure, which indicates risk of future bearish movement.
MTNB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.67 | Sell |
| Relative Strength Index (14 RSI): | 24.04 | Sell |
| Chaikin Money Flow: | 48569 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.88 - 3.58) | Sell |
| Bollinger Bands (100): | (-0.05 - 3.15) | Sell |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 32.22 | Buy |
| Relative Strength Index (14 RSI): | 65.08 | Buy |
| Chaikin Money Flow: | -444993 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (198.88 - 318.12) | Buy |
| Bollinger Bands (100): | (218.14 - 292) | Buy |
MTNB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.66 | Buy |
| 20-day SMA: | 1.98 | Sell |
| 50-day SMA: | 2.87 | Sell |
| 200-day SMA: | 0.88 | Sell |
| 8-day EMA: | 0.88 | Sell |
| 20-day EMA: | 1.59 | Sell |
| 50-day EMA: | 2.04 | Sell |
| 200-day EMA: | 1.22 | Sell |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 338.36 | Sell |
| 20-day SMA: | 269.76 | Buy |
| 50-day SMA: | 242.53 | Buy |
| 200-day SMA: | 245.55 | Buy |
| 8-day EMA: | 323.3 | Sell |
| 20-day EMA: | 288.35 | Buy |
| 50-day EMA: | 259.62 | Buy |
| 200-day EMA: | 242.47 | Buy |
Matinas BioPharma Holdings Earnings Growth & MTNB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.15 per share, and an increase next year of $1.35 per share.
Madrigal Pharmaceuticals Earnings Growth & MDGL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $4.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.14 per share, and an increase next year of $9.75 per share.
Matinas BioPharma Holdings Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||